The global nasalcannula market by Product Type (Low-flow Cannula, High-flow Cannula, andOthers), by Application (Cancer, Respiratory Diseases , CardiovascularDiseases, and Others), by End User (Hospitals, Neonatal Intensive Care Units,Home Care Settings, and Others), and by Region (North America, Latin America,Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 4,234.5million in 2017, and is projected to exhibit a CAGR of 7.4% over the forecastperiod (2018–2026).
The global nasal cannula marketis expected to witness significant growth over the forecast period, owing tofactors such as product development and high prevalence of diseases includingchronic obstructive pulmonary respiratory diseases (COPD), lung cancer, andstroke. Moreover, initiatives taken by several organizations related totreatment and awareness of respiratory diseases is expected to support theglobal nasal cannula market growth over the forecast period. Manufacturers arefocusing on developing new products and introducing new technology in themarket. For instance, in January 2016, UODPS LLC launched a product: Uniflo-2single nasal cannula, which was designed using ultra-smooth materials. It doesnot contain any rubber latex, which minimizes the exposure to Di-2-ethylhexylphthalate (DEHP), thereby preventing irritation. It consists of memorystabilizer and ensures continuous flow of air. In June 2018, the companyconducted a survey wherein opinions were recorded from COPD patients usingUniflo 2 single nasal cannula.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2694
The study revealed that almost98% patients found this cannula as more comforting than dual prong nasalcannula. It allows minimum skin contact so as to avoid skin irritation, whichoccurs in dual prongs and is almost half in weight as compared to dual prongnasal cannulas. Moreover, in October 2018, Vapotherm Inc. received an approvalfrom the U.S. Food and Drug Administration (FDA) for Precision Flow Hi-VNIsystem (respiratory system), which involves designed nasal cannulas that assisthigh flow oxygen therapy.
Browse 26 Market Data Tables and32 Figures spread through 168 Pages and in-depth TOC on Global Nasal CannulaMarket by Product Type (Low-flow Cannula, High-flow Cannula, and Others), byApplication (Cancer, Respiratory Diseases, Cardiovascular Diseases, andOthers), by End User (Hospitals, Neonatal Intensive Care Units, Home CareSettings, and Others), and by Region (North America, Latin America, Europe,Asia Pacific, Middle East, and Africa) - Global Forecast to 2026
High prevalence of COPD may leadto increasing demand for nasal cannula, thereby boosting the global nasalcannula market growth over the forecast period. According to World HealthOrganization (WHO), approximately 65 million people suffer from moderate tosevere COPD and around 3 million deaths are recorded every year globally.Moreover, COPD is the third leading cause of death worldwide. According to thesame source, acute lower respiratory tract infections are responsible foraround 4 million deaths in children aged less than 5 years, worldwide annually.Moreover, preterm infants are associated with complications related to breathingdifficulties. According to WHO, in 2018, approximately 15 million infants wereborn premature, worldwide. Nasal cannula can be used to give an accurate amountof airflow to children. Therefore, increasing prevalence of COPD in childrenand adults is expected to drive the global nasal cannula market growth over theforecast period.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/nasal-cannula-market-2694
Key Takeaways of the Global NasalCannula Market:
The global nasal cannula marketis expected to exhibit a CAGR of 4% over the forecast period (2018–2026), dueto vast number of products offered by manufacturers, which broadens the rangeof available options to customers
Increasing prevalence of diseasessuch as lung cancer, stroke, and COPD may lead to high demand for nasalcannulas, thereby supporting the global nasal cannula market growth over theforecast period
Major players operating in theglobal nasal cannula market include, Sunset Healthcare Solutions Inc.,Flexicare Ltd., medin Medical Innovations GmbH, Salter Labs, Smiths Medical,Teleflex Inc., Neotech Products, Fairmont Medical, Medline Industries Inc., andHamilton Medicals
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2694
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
